Par Drugs & Chemicals Ltd share price logo

Par Drugs Share Price

NSE: PAR

BSE: 535341

Small Cap

Healthcare Sector

₹98.11

-1.20

(-1.21%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Par Drugs Stock Performance

as on February 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹97.00
    ₹99.95
    downward going graph

    1.13%

    Downside

    1.88%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹81.01
    ₹141.88
    downward going graph

    17.43%

    Downside

    44.61%

    Upside

    downward going graph

Par Drugs share price movements today

Previous Close
₹99.31
Open
₹99.31
Volume
5,533.00
Upper Circuit
₹119.17
Lower Circuit
₹79.45
Day's Low - High
₹97.00 - ₹99.95
52 Week Low - High
₹81.01 - ₹141.88

Par Drugs Historical Returns

1 Month Return
+ 12.3 %
3 Month Return
+ 7.19 %
1 Year Return
-22.44 %
3 Year Return
-34.04 %
5 Year Return
+ 183.91 %

Par Drugs Fundamentals

as on February 20, 2026 at 4:01 pm IST

Market Cap

₹122.20 Cr

Return on Equity (ROE)

14.47

PE Ratio (TTM)

0

Return on capital employed (ROCE)

19.48

Beta (LTM)

0.87

P/B Ratio

1.06

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

727.59

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Par Drugs & Chemicals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Par Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Par Drugs & Chemicals Ltd image
Par Drugs & Chemicals Ltd
NA122.2036.78%0.0013100
Vilin Bio Med Ltd image
Vilin Bio Med Ltd
NA49.384.84%0.00114
Sanjivani Paranteral Ltd image
Sanjivani Paranteral Ltd
NA239.97331.98%0.61870
Viyash Scientific Ltd image
Viyash Scientific Ltd
NA9,418.72-2.12%0.72321,551
Gujarat Terce Laboratories Ltd image
Gujarat Terce Laboratories Ltd
NA30.5494.17%0.00-150
See all

Par Drugs Stock’s Investor Sentiment and Interest

Search interest for Par Drugs & Chemicals Ltd Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:43% versus previous 30 day period

Par Drugs & Chemicals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
24.49
22.93
25.89
24
22.82
22.61
34.66
21.38
22.33
26.05
28.66
29.34
Other Income
0.03
0.01
0.05
0.23
-0.05
0.07
1.02
0.27
0.79
1.84
0.48
1.33
Total Income
24.52
22.95
25.94
24.23
22.77
22.68
35.67
21.65
23.12
27.88
29.14
30.67
Expenses
19.11
18.8
18.52
18.77
16.73
18.37
23.25
19.95
19.9
22.49
22.59
23.28
Operating Profit
5.38
4.13
7.37
5.23
6.09
4.24
11.41
1.43
2.43
3.56
6.07
6.06
Operating Profit Margin %
21.97%
18.01%
28.47%
21.79%
26.69%
18.75%
32.92%
6.69%
10.88%
13.67%
21.18%
20.65%
Profit Before Interest, Tax and Depreciation
5.41
4.14
7.41
5.46
6.05
4.31
12.42
1.7
3.22
5.4
6.55
7.39
Interest
0.03
0.02
0.03
0.02
0.05
0.02
0.03
0.01
0.02
0.02
0.05
0.01
Depreciation
0.85
0.83
0.85
0.87
0.89
0.9
0.91
0.91
0.92
0.9
0.94
0.93
Profit Before Tax
4.53
3.29
6.53
4.57
5.11
3.39
11.48
0.78
2.28
4.48
5.56
6.45
Tax Paid
1.09
0.83
1.65
1.15
1.39
0.85
2.89
0.19
0.63
1.15
1.42
1.64
Profit After Tax
3.45
2.47
4.89
3.42
3.72
2.53
8.6
0.58
1.65
3.33
4.13
4.8
Total Net profit including share of profit / Loss from associate company
3.45
2.47
4.89
3.42
3.72
2.53
8.6
0.58
1.65
3.33
4.13
4.8
EPS
2.8
2.01
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9
Actual EPS
2.8
2.01
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9
Adjusted EPS
2.8
2.01
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9
Diluted EPS
2.8
2.01
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9

Par Drugs & Chemicals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
42.38
46.32
55.85
60.75
75.07
95.75
95.64
100.97
Other Income
0.04
0.09
0.1
2.18
0.18
0.24
0.24
2.15
Total Income
42.42
46.41
55.95
62.93
75.26
95.99
95.88
103.12
Expenses
34.35
38.12
46.4
44.74
58.82
77.54
72.82
81.47
Operating Profit
8.03
8.2
9.45
16.01
16.25
18.21
22.82
19.5
Operating Profit Margin %
18.95%
17.7%
16.92%
26.35%
21.65%
19.02%
23.86%
19.31%
Profit Before Interest, Tax and Depreciation
8.07
8.29
9.55
18.19
16.44
18.45
23.06
21.65
Interest
2.33
1.96
0.79
0.64
0.45
0.13
0.11
0.08
Depreciation
3.14
3.04
2.76
2.82
3.28
3.23
3.44
3.65
Profit Before Tax
2.6
3.29
6
14.73
12.71
15.09
19.51
17.92
Tax Paid
1.07
0.78
1.23
3.11
3.49
3.75
5.02
4.57
Profit After Tax
1.52
2.51
4.77
11.61
9.21
11.33
14.5
13.36
Total Net profit including share of profit / Loss from associate company
1.52
2.51
4.77
11.61
9.21
11.33
14.5
13.36
EPS
5.64
5.6
7.75
18.87
7.49
9.21
11.78
10.86
Actual EPS
5.64
5.6
7.75
18.87
7.49
9.21
11.78
10.86
Adjusted EPS
2.82
2.8
3.88
9.44
7.49
9.21
11.78
10.86
Diluted EPS
5.64
5.6
7.75
18.87
7.49
9.21
11.78
10.86

Par Drugs & Chemicals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
6.53
9.17
4.32
2.1
7.69
12.09
7.62
13.38
20.25
16.16
Cash Flow from Investing Activities
-0.17
-1.7
-0.6
-0.25
-1.45
0.05
-3.02
-7.33
-5.84
-25.24
Cash Flow from Financing Activities
-5.46
-8.38
-3.67
-1.87
1.12
1.65
-9.56
-
-
-
Net Cash Flow
0.9
-0.91
0.05
-0.03
7.35
13.78
-4.96
6.04
14.41
-9.08

Par Drugs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
74.21%
74.21%
74.21%
74.21%
74.21%
74.21%
73.37%
73.37%
73.37%
73.37%
73.37%
73.41%
FII
0%
0%
0%
0.07%
0%
0%
0%
0%
0%
0%
0%
0%
Public
25.79%
25.79%
25.79%
25.73%
25.68%
25.47%
26.54%
26.63%
26.63%
26.63%
26.63%
26.59%
Total Outstanding Shares
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
Total Shareholders
5,585
5,686
5,902
7,020
7,403
8,022
8,757
17,199
15,472
14,887
14,280
13,761

Par Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Par Drugs.

  • Par Drugs & Chemicals Ltd Earnings Results

    Par Drugs & Chemicals Ltd’s net profit jumped 727.59% since last year same period to ₹4.80Cr in the Q3 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 16.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Par Drugs & Chemicals Ltd Dividends November,2021

    In the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 per share on 09 Nov 2021 - translating a dividend yield of 1.26%.

    Read More about Dividends

Insights on Par Drugs & Chemicals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, PAR stock has moved up by 7.1%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 73.37% to 73.41% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 186.4% return, outperforming this stock by 220.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 40.3% return, outperforming this stock by 59.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 26.63% to 26.59% in Dec 2025 quarter

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited is an Indian company which is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for both domestic and international markets. It was initially incorporated as a private limited company in Bhavnagar, Gujarat and later converted into a public limited company in October 2018. It has two manufacturing facilities at Bhavnagar and Ankleshwar in Gujarat, comprising of 3 manufacturing blocks for APIs and 2 for Fine Chemicals in Bhavnagar. The company produces a range of popular antacid molecules and markets a total of 12 APIs and 6 Fine Chemicals domestically and for exports to 16 countries. Key customers of the company include Essential Drugs Company Limited, Taurus Chemicals P Limited, Pfizer Limited, United Phosphorus Limited, Samba Jammu Unit and Shiv Silica Private Limited.

Revenue: ₹29.34Cr as on December 2025 (Q3 FY26)
Net Profit: ₹4.80Cr as on December 2025 (Q3 FY26)
Listing date: 16 May, 2019
Chairperson Name: FALGUN VALLABHBHAI SAVANI
OrganisationPar Drugs & Chemicals Ltd
IndustryPharmaceuticals
CEOFALGUN VALLABHBHAI SAVANI
E-voting on sharesClick here to vote

FAQs

What is Par Drugs share price today?

Par Drugs share price today stands at ₹98.11 as on at the close of the market. Par Drugs share today touched a day high of ₹99.95 and a low of ₹97.

What is the 52 week high and 52 week low range for Par Drugs share?

Par Drugs touched a 52 week high of ₹141.88 and a 52 week low of ₹81.01. Par Drugs share price today i.e. is closed at ₹98.11, which is -30.85% down from its 52 week high and 21.11% up from its 52 week low.

What is Par Drugs's market capitalisation today?

Par Drugs market capitalisation is ₹122.20 Cr as on .

How to buy Par Drugs shares?

To buy Par Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PAR or Par Drugs & Chemicals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Par Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Par Drugs trading volume today?

Par Drugs trading volume is 5,533.00 as on . This means that 5,533.00 shares of Par Drugs were bought and sold on the stock market during today's trading session.